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Using FGF-2 HSGAGs as a model, de Paz and colleagues [1] have demonstrated the importance of
multivalency in cooperative glycan-protein interactions to achieve specificity.Heparin and heparan sulfate glycos-
aminoglycans (HSGAGs) are complex
polysaccharides that are primary
components on the cell surface and
extracellular matrix (ECM). Due to their
ubiquitous distribution at the cell-ECM
interface, HSGAGs interact with nu-
merous proteins and modulate their
activity, and thus impinge on funda-
mental biological processes such as
cell growth, development, inflamma-
tion, immune response, microbial in-
fection, and cancer [2]. HSGAGs are
composed of a disaccharide repeat
unit of a-D-glucosamine linked 1/4
to a-L-iduronic (IdoA) or b-D-glucur-
onic acid (GlcA). Each repeat unit in
the HSGAG backbone can be modi-
fied via sulfation at the 2-O position
of the uronic acid, and 3-O and 6-O
of the glucosamine. The N-position of
glucosamine can be sulfated (GlcNS)
or acetylated (GlcNAc). HSGAGs are
synthesized as O-linked glycosylation
at a consensus motif of Ser-Gly/
Ala-X-Gly in a core protein (HSGAG
and protein together are known as
proteoglycan).
The biosynthesis of HSGAGs is a
complex nontemplate driven process
involving several enzymes which give
rise to regions of distinct sulfation pat-
terns [3, 4]. By utilizing this complex
biosynthetic machinery, the cell main-
tains a diverse set of HSGAG chains
on the cell surface and thus dynami-
cally changes its environment in re-
sponse to biochemical signals. It is
generally believed that HSGAG bio-
synthesis results in stretches of highly
sulfated (NS) domains that are inter-
vened by undersulfated GlcNAc (NA)
domains [5]. Thus, a large diversity in
HSGAG sequences arising from their
sulfation pattern and epimeric state
of the uronic acid facilitates bindingto a variety of proteins such as growth
factors, enzymes, morphogens, and
surface proteins on microbial patho-
gens in the extracellular environment.
The emerging view is that the biologi-
cal activity of many HSGAG-binding
signaling molecules is mediated by
the specificity of HSGAG-protein inter-
actions [2]. Given the abundance of
HSGAG in the cell surface-ECM inter-
face it is important to understand what
governs the specificity of glycan-pro-
tein interactions. It is generally viewed
that short stretches of NS separated
by the NA domains can provide the
appropriate binding template formono-
meric, as well as oligomeric, HSGAG
binding proteins. The appropriate
length and distribution of the NS and
NA domains could thereby confer the
needed binding specificity [5, 6].
The interaction between HSGAGs
and the fibroblast growth factor (FGF)
family (specifically FGF-1 and FGF-2)
is one of the best-characterized sys-
tems. The overall mechanism of FGF
signaling involves binding of FGF to
cell surface HSGAGswhich act as cor-
eceptors to facilitate FGF oligomeriza-
tion and binding of FGF to its tyrosine
kinase receptors (FGFRs) on the cell
surface, leading to FGFR oligomeriza-
tion and subsequent activation of MAP
kinase signaling pathway. Therefore,
HSGAGs are involved in multivalent
interactions with multiple FGF mole-
cules, facilitating their oligomerization,
and with FGFR molecules, facilitating
formation of multimeric assembly of
FGF-FGFR complexes.
The length of HSGAG chain, sulfa-
tion pattern, and conformation of the
IdoA residue are critical determinants
of HSGAG-mediated FGF signaling.
Structural studies on unboundHSGAG
oligosaccharides point to a helicalChemistry & Biology 14, August 2007structure with 21 symmetry. Binding
to FGF-1 and FGF-2 induces a kink
in the helical structure of the oligosac-
charide and this kink spans a trisac-
charide motif of the form -GlcNS,
6S-IdoA2S-GlcNS,6S- [2]. The mini-
mal FGF-1 and FGF-2 binding motif
in HSGAGs appears to be a tetrasac-
charide which is composed of the
trisaccharide spanning kink and an
IdoA2S sugar at the reducing or nonre-
ducing end of this trisaccharide [2, 7].
In both FGF-1 and FGF-2, the kink
positions the NS and 2S groups to
provide maximum contact with the
HSGAG binding site. On the other
hand, while the 6S group interacts
with FGF-1, it does not make signifi-
cant contact with FGF-2 [8, 9]. The po-
sitioning of these minimal FGF-binding
tetrasaccharide motifs in the context
of chain length (and distribution) plays
a critical role in association of FGF
oligomers, as well as FGF-FGFR com-
plexes. In the case of FGF-1, the mini-
mal tetrasaccharide motif binds to two
FGF-1 monomers to form a HSGAG
bridged FGF-1 dimer complex [8].
Unlike FGF-1, FGF-2 self-associates,
even in the absence of HSGAGs, to
form dimers and higher order oligo-
mers that facilitate FGF-2 signaling.
HSGAGs containing multiple FGF
binding tetrasaccharide motifs within
a sufficient chain length (octasacchar-
ideat least) stabilize and facilitate these
active FGF-2 oligomers. However,
shorter HSGAG chains can bridge two
FGF-2 monomers in an inactive state,
sequestering them in the ECM.
In the diverse sequence space of
HSGAGs at the cell-ECM interface,
the presence of such defined tetrasac-
charide motifs in the right context of
chain length for biological specificity
in FGF signaling is expected to be inª2007 Elsevier Ltd All rights reserved 873
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Previewslow abundance. Importantly, there is
multivalency in both FGF-2 associa-
tion and HSGAG presentation as mul-
tiple chains on one or more proteogly-
cans. This multivalency enhances the
cooperativity of HSGAG-FGF-2 inter-
actions particularly given the lowmolar
abundance of defined protein binding
oligosaccharide motifs. The positive
effect of multivalency enhancing FGF
signaling was demonstrated using an
engineered construct of an FGF-2 di-
mer [10]. It was demonstrated both
in vitro and in vivo that much lower
doses of the dimeric form of FGF-2
were sufficient to attain the maximum
signaling response in comparison
with monomeric FGF-2.
While most of the studies on FGF-2-
HSGAG interactions have focused on
multivalency in FGF-2 association, the
study by de Paz et al. [1] in this issue
of Chemistry & Biology has provided
important insights into effects of multi-
valency in the presentation of HSGAG
chains.Amine functionalizedendgroups
have been utilized to attach multiple
oligosaccharides to the polyamido-
amine dendrimers resulting in about
eight oligosaccharides per dendrimer.
Elegant coupling chemistries have
been utilized to perform binding stud-
ies on heparin-coated microarrays
and SPR analysis on CM5 gold chip.
Dendrimer 1 used in this study [1]
composed of multiple HSGAG hexa-
saccharides (containing the minimal
FGF-2 binding tetrasaccharide motif)
shows the strongest binding to FGF-2
in comparison with other dendrimers.
Importantly this multivalent dendrimer
shows significantly higher affinity to
FGF-2 as compared to the monomeric
form of the same hexasaccharide
(compound 6) used in this study [1].
The fact that dendrimers of disaccha-
rides and monosaccharides show only
weak to moderate affinity despite the
multivalent presentation reflects the
minimum requirement of tetrasacchar-874 Chemistry & Biology 14, August 2007ide chain length for optimal FGF-2
binding. In the cell culture experiments
to measure FGF-2 signaling, den-
drimer 1, and not hexasaccharide 6,
caused an increased expression of
phosphorylated ERK-1 (downstream
FGF-2 signaling molecule). The inabil-
ity of the hexasaccharide to activate
FGF-2 signaling is consistent with
other studies that demonstrate that
longer HSGAG oliogsaccharides are
required for FGF-2 signaling [11].
However, the multivalent presentation
of the hexasaccharide in dendrimer 1
appears to circumvent this require-
ment by facilitating the assembly of
FGF2-FGFR complexes for FGF-2 sig-
naling. The positive control for binding
used in this study [1] is a 5 kDa heparin
which is composed of longer oligosac-
charides up to hexadecasaccharide
chain length. Such long chains are
likely to have multiple FGF-2 binding
tetrasaccharide motifs and this is re-
flected by the much higher affinity of
the 5 kDa heparin to FGF-2 as com-
pared to dendrimer 1. These results
point to distinct effects of the kind of
multivalency—presentation of multiple
FGF-2 binding tetrasaccharide motifs
in a longer chain versus single motif
on multiple shorter chains—on FGF-2
association, FGF-FGFR interactions,
and FGF signaling.
Earlier studies have shown that
different HSGAG affinities to FGF gen-
erally correlate with the degree of sul-
fation [11]. This has led to the notion
that nonspecific charge interaction
may also exist in the formation of an
FGF-HSGAG-FGFR complex [6]. Chal-
lenges in the past have been primarily
due to mimicking physiological multi-
valent interactions while performing
binding studies using defined HSGAG
oligosaccharides. The current study
and others have demonstrated the
need for multivalency to provide the
appropriate specificity for HSGAG-
protein interactions. However, theª2007 Elsevier Ltd All rights reservedconcept of multivalency has also con-
founded the views of biologists as it is
challenging to grapple with the issue
of specificity, given the fact that affin-
ity can be altered by multivalency in
biochemical experiments. The work
reported by de Paz and colleagues
has contributed toward the under-
standing of multivalent HSGAG-pro-
tein interactions.
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